Poxel SA (LTS:0RA2)
€ 0.1424 0 (0%) Market Cap: 7.53 Mil Enterprise Value: 52.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 8/100

Full Year 2021 Poxel SA Earnings Call Transcript

Mar 22, 2022 / 06:00PM GMT
Release Date Price: €2.72 (+0.63%)
Operator

This meeting is being (technical difficulty)

Unidentified Company Representative

(technical difficulty) communication of annual its results. I am joined by (inaudible) CEO of Poxel; and Renevot, CFO; and David Moller, CSO of the company. During this webinar, management will review its final results and will be available to answer your questions following the presentation. (Operator Instructions) I will now hand over to Thomas.

Thomas Kuhn
Poxel S.A. - Co-Founder, CEO & Director

Thank you, [Nicolas]. Thank you for joining us today. I'm Thomas Kuhn, I'm the CEO of Poxel. After my introductory comments, I will hand the call to Anne Renevot, our CFO, to review the full year 2021 financial results. And then David Moller, our Chief Scientific Officer, will provide an update on our clinical [buyback].

Before we begin, let's review our forward-looking statements. Forward-looking statements are subject to inherent risks and uncertainties beyond the company's control that could cause the company's actual results or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot